Toward a genome-scale understanding of group A Streptococcus pathogenesis

Current Opinion in Microbiology

Volumn 4, Issue 1, 2001, Pages 65-70

  Graham, Morag R ^a   Smoot, Laura M ^a   Lei, BenFang ^a   Musser, James M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS VACCINE;

ALLERGIC GLOMERULONEPHRITIS; BACTERIAL GENE; BACTERIAL VIRULENCE; DNA PROBE; DNA SEQUENCE; EPIDEMIC; GENE CONTROL; GENE FUNCTION; GENE SEQUENCE; GENETIC CODE; GENOME; HOST RESISTANCE; NONHUMAN; PATHOGENESIS; REVIEW; SEQUENCE ANALYSIS; SEROTYPE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; VACCINATION;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS SP. 'GROUP A';

EID: 0035147551     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(00)00166-1     Document Type: Review

References (46)

1. The revival of Group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome
2. Pathogenesis of Group A streptococcal infections
3. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: An integrin-binding cysteine protease
4. High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements
5. Human immune response to streptococcal inhibitor of complement (Sic), a serotype M1 Group A Streptococcus extracellular protein involved in epidemic waves
6. Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves
7. Regulation of mga transcription in the group A Streptococcus: Specific binding of Mga within its own promoter and evidence for a negative regulator
8. The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production
9. A response regulator that represses transcription of several virulence operons in the group A streptococcus
10. Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins
11. Characterization of nra, a global negative regulator gene in group A streptococci
12. The RofA binding site in Streptococcus pyogenes is utilized in multiple transcriptional pathways
13. New multideterminant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population
14. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments
15. 3
16. Proteomics, DNA arrays and the analysis of still unknown regulons and unknown proteins of Bacillus subtilis and pathogenic Gram-positive bacteria
17. The analysis of microbial proteomes: Strategies and data exploitation
18. Biomedical discovery with DNA arrays
19. Global gene expression profiles of Bacillus subtilis grown under anaerobic conditions
20. Invasive group A streptococcal disease in the Netherlands: Evidence for a protective role of anti-exotoxin A antibodies
21. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes
22. Characterization of a two-component system in Streptococcus pyogenes which is involved in regulation of hyaluronic acid production
23. Streptococcal erythrogenic toxin B abrogates fibronectin-dependent internalization of Streptococcus pyogenes by cultured mammalian cells
24. Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein
25. Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes
26. 1-fibronectin-M1 protein complexes
27. New protective antigen of group A streptococci
28. Replacement of histidine 340 with alanine inactivates the group A Streptococcus extracellular cysteine protease virulence factor
29. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B
30. An IgA-binding peptide derived from a streptococcal surface protein
31. Capsular hyaluronic acid of group A streptococci hampers their invasion into human pharyngeal epithelial cells
32. Protein H, an antiphagocytic surface protein in Streptococcus pyogenes
33. Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells
34. Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model
35. Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization
36. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice
37. Lactobacilli and streptococci activate NF-κB and STAT signaling pathways in human macrophages
38. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors
39. 2-macroglobulin
40. Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate
41. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells
42. Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo
43. Group A Streptococcus: Allelic variation, population genetics and host-pathogen interactions
44. Identification and immunogenicity of group A Streptococcus culture supernatant proteins